Granulysin and the antimicrobial activity of CD8T cells - development of a better model
Granulysin and the antimicrobial activity of CD8T cells - development of a better model
批准号:
10192536
负责人:
SAMUEL M BEHAR
金额:
$20.94万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-02-18 至 2023-01-31
关键词:
AddressAdoptive TransferAerosolsAnti-Bacterial AgentsAntigensAttenuatedBacteriaBacterial Artificial ChromosomesBiochemicalBiochemistryCD3 AntigensCD8-Positive T-LymphocytesCause of DeathCell CountCell LineCell LineageCell physiologyCellsComplementary DNACytoplasmic GranulesCytosolDataDevelopmentDiseaseDoseDrug resistance in tuberculosisFlow CytometryGene TransferGenesGranulomaGranzymeHumanImmunityIn VitroIndividualInfectionInfectious AgentInvestigationJurkat CellsLentivirus VectorListeria monocytogenesLungMacaca fascicularisMeasuresMediatingMicrobeModelingMusMycobacterium bovisMycobacterium tuberculosisNatural Killer CellsOrthologous GeneOutcomeOvumPeptidesPhysiologic pulsePlayProtein IsoformsProteinsPulmonary TuberculosisRNARecoveryResearch ProposalsRetroviral VectorRodentRoleStudy modelsSystemT cell responseT-Cell ActivationT-LymphocyteTestingTranscriptTransgenic MiceTuberculosisTuberculosis VaccinesVaccinatedVaccinesVirulentVirusadaptive immunityantimicrobialarmcytokinecytotoxiccytotoxic CD8 T cellsglobal healthgranulysinhuman modelimprovedin vivointerestmacrophagemouse genomemouse modelnonhuman primatepathogenpathogenic bacteriaperforinretroviral-mediatedsingle-cell RNA sequencingtuberculosis immunitytumorvaccine-induced immunity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract. CD8 T cells are an important arm of adaptive immunity, and make critical contributions to
protection against viruses, other intracellular pathogens, and tumors. Our lab has a long-standing
interest in the role of CD8 T cells in immunity to tuberculosis (TB), which is the leading cause of death
in the world from an infectious agent. Recent data from the non-human primate (NHP) model of TB
shows that CD8 T cells make a crucial contribution to both primary and vaccine-mediated immunity
against Mycobacterium tuberculosis (Mtb) [1-5]. Increases in CD8 T cell number and function are
associated with vaccine-induced protection in the NHP TB model. Furthermore, using single cell
RNASeq, cytotoxic NK and CD8 T cells are significantly associated with host-beneficial outcome (i.e.,
Mtb control). Importantly, CTL frequently associated with restrictive granulomas more frequently
express the combination of perforin, granzymes, and granulysin. Granulysin (GNLY) is an important
cytotoxic granule component produced by cytotoxic CD8 T cells and NK cells, and can kill many
different types of intracellular bacterial pathogens. The granulysin protein has antimicrobial activity
against Mtb when directly applied to bacteria and can kill drug resistant Mtb strains [6]. However, it
has been difficult to study the role of granulysin in the mouse model, as rodents lack an ortholog of
the gene. A human granulysin transgenic mouse (hGNLY-tg) was developed by Allan Krensky [7]. In
that mouse, granulysin is expressed primarily in NK cells, and in CD8 T cells only after vigorous in
vitro stimulation. Here, we propose to develop new mouse models to study the role of granulysin in
antimicrobial immunity. Our approach will address whether granulysin expression is crucial for CD8 T
cell control of Mtb. Our expression system will enable better modelling of human CD8 T cell
responses in the mouse. This model will provide an experimental system to support investigation of
the role of granulysin in immunity to TB. We hypothesize that the suboptimal antibacterial function of
CD8 T cells in the murine model is their lack of granulysin expression. A corollary is that granulysin
expression by murine CD8 T cells would improve their ability to control Mtb infection after low dose
aerosol Mtb infection. We will answer this question as part of this project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of CD38 in immunity to tuberculosis
-
批准号:10727585
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2023
-
负责人:SAMUEL M BEHAR
-
依托单位:
Hypoxia, tuberculosis, and T cell dysfunction
-
批准号:10735553
-
项目类别:
-
资助金额:$72.97万
-
财政年份:2023
-
负责人:SAMUEL M BEHAR
-
依托单位:
Granulysin and the antimicrobial activity of CD8T cells - development of a better model
-
批准号:10356169
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2021
-
负责人:SAMUEL M BEHAR
-
依托单位:
Overcoming Genetic Variation in Vaccination
-
批准号:10219089
-
项目类别:
-
资助金额:$42.52万
-
财政年份:2017
-
负责人:SAMUEL M BEHAR
-
依托单位:
Tuberculosis and T cell Recognition
-
批准号:9081934
-
项目类别:
-
资助金额:$73.55万
-
财政年份:2016
-
负责人:SAMUEL M BEHAR
-
依托单位:
Tuberculosis and T cell Recognition
-
批准号:9221970
-
项目类别:
-
资助金额:$69.83万
-
财政年份:2016
-
负责人:SAMUEL M BEHAR
-
依托单位:
Regulation of CD8+ T cell immunity to tuberculosis (pending title)
-
批准号:8550320
-
项目类别:
-
资助金额:$60.56万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
Regulation of CD8+ T cell immunity to tuberculosis (pending title)
-
批准号:8884534
-
项目类别:
-
资助金额:$64.78万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
Apoptosis and efferocytosis: regulators of immunity to tuberculosis
-
批准号:8993894
-
项目类别:
-
资助金额:$49.62万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
Apoptosis and efferocytosis: regulators of immunity to tuberculosis
-
批准号:8791297
-
项目类别:
-
资助金额:$49.62万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
Tim3 and Mycobacterium tuberculosis
-
批准号:8652944
-
项目类别:
-
资助金额:$52.91万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
Apoptosis and efferocytosis: regulators of immunity to tuberculosis
-
批准号:8605506
-
项目类别:
-
资助金额:$49.54万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
Tim3 and Mycobacterium tuberculosis
-
批准号:8629422
-
项目类别:
-
资助金额:$49.44万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
The effect of type I IFN and IL-12 signaling on T cell immunity to tuberculosis
-
批准号:8629409
-
项目类别:
-
资助金额:$20.81万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
Regulation of CD8+ T cell immunity to tuberculosis
-
批准号:10397020
-
项目类别:
-
资助金额:$70.46万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
Regulation of CD8+ T cell immunity to tuberculosis (pending title)
-
批准号:8711279
-
项目类别:
-
资助金额:$64.78万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
Regulation of CD8+ T cell immunity to tuberculosis
-
批准号:9918239
-
项目类别:
-
资助金额:$70.46万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
Apoptosis and efferocytosis: regulators of immunity to tuberculosis
-
批准号:8629352
-
项目类别:
-
资助金额:$33.82万
-
财政年份:2013
-
负责人:SAMUEL M BEHAR
-
依托单位:
The effect of type I IFN and IL-12 signaling on T cell immunity to tuberculosis
-
批准号:8331116
-
项目类别:
-
资助金额:$23.02万
-
财政年份:2012
-
负责人:SAMUEL M BEHAR
-
依托单位:
Apoptosis and efferocytosis: regulators of immunity to tuberculosis
-
批准号:8416345
-
项目类别:
-
资助金额:$9.89万
-
财政年份:2012
-
负责人:SAMUEL M BEHAR
-
依托单位:
海外基金